References
- Bos J. The ras gene family and human carcinogenesis. Mutat Res 1988; 195: 255–271
- Bos J. ras oncogenes in human cancer: A review. Cancer Res 1989; 49: 4682–4689
- Carter BS, Epstein JI, Issacs WB. rus gene mutations in human prostate cancer. Cancer Res 1990; 50: 6830–6832
- Saiki RK. Principles and applications for DNA amplification. PCR Technology, HA. Erlich. Stockton Press, New York 1989, Chapter 1
- Sambrook J, Fritsch EF, Maniatis T. In Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor. NY 1989
- Kato Y, Kitamura T, Mitsui A, Yamasaki Y, Hashimoto T, Murotsu T, Fukushige S, Matsubara K. Separation of DNA restriction fragments by HPLC ion exchange chromatography on a non-porous ion exchanger. The ras family and human carcinogenesis. J Chromatogr 1989; 478: 264–268
- Webber MN. Growth and maintenance of normal prostatic epithelium in vitro—A human cell model. Progress in Clinical and Biological Research, G. Murphy. Alan R Liss, New York 1980; Vol 37: 181–216
- Silverberg E, Boring C, Squire TS. Cancer statistics. CA 1990; 40: 9–26
- Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J, Hand P, Thor A, Schlom J. Expression of rus oncogene p21 in prostate cancer. N Engl J Med 1986; 314: 133–137
- Varma VA, Austin GE, O'Connell AC. Antibodies to ras oncogene p21 proteins lack immunohistochemical specificity for neoplastic epithelium in human prostate tissue. Arch Pathol Lab Med 1989; 113: 16–19
- Nag A, Jones JA, Smith RG. Point mutation in c-H ras oncogene in normal and abnormal cells. Lancet 1989; 668: 274–275
- Victor T, Dutoit R, Jordaan AM, Bester AJ, Van Helden PD. No evidence for point mutations in codons 12, 13 and 61 of the ras gene in a high incidence area for esophageal and gastric cancers. Cancer Res 1990; 50: 4911–4914
- Konishi N, Enomoto T, Ohshima N, Ward JM, Rice JM. K-ras activation and ras p21 expression in human prostatic carcinomas. Proc Am Assoc Cancer Res. 1990; 31: 225
- Carter BS, Epstein JI, Isaacs WB. ras gene mutations in prostate cancer. Proc Am Assoc Cancer Res 1990; 31: 314
- Peehl DM, Wehner N, Stamey TA. Activated Ki-ras oncogene in human prostatic adenocarcinoma. Prostate 1987; 10: 281–289
- Kaighn ME, Shankar Narayan K, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 1979; 16: 16–23
- Horoszewicz JS, Leong SS, Ming Chu T, . The LnCap cell line—A new model for studies on human prostatic carcinoma. Models for Prostate Cancer, G. Murphy, et al. Alan R Liss, New York 1980; 115–132